REGISTER Clinical trials are essential for evaluating potential new treatments, advancing the standard of care, and improving ...

But before any of these disparate approaches can begin to affect the rate of cancer mortality, they must pass through the bottleneck of human clinical trials. The pace of new ideas through the ...

Clinical trials are conducted in several phases to determine whether new treatments are safe and effective. The results from Phases 1, 2 and 3 inform the U.S. Food and Drug Administration (FDA) on ...

The following is a summary of “Community Leaders’ Perceptions of Pain and Research Engagement: Implications for Participant Diversity and Inclusion in Pain Clinical Trials,” published in the April ...

What are the barriers preventing equitable access to care and clinical trials? BlackDoctor.org presents a vital panel discussion.

Karen Winkfield, MD, PhD, addresses the importance of meeting patients where they are to expand clinical trial participation and remove barriers to trial access. Editor’s note: An earlier ...

Research from Harvard Kennedy School’s Marcella Alsan shows Black survey respondents’ interest in clinical trials increased ...

We need to make clinical trial participation a seamless experience for patients, build relationships between patients and site staff, and remove logistical barriers to participation for the good ...

"At ProofPilot, we're committed to transforming the clinical trial experience for both ... to work with Inspire to break down barriers to study participation." Founded in 2005, Inspire connects ...

Looking at those barriers, it is estimated ... approximately 20% of cancer clinical trials fail due to insufficient patient participation," Shackleford said. The measure was approved 95-0 by ...